Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
31 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250531848054/en/Zai-Lab-and-Novocure-Announce-Results-From-the-Phase-3-PANOVA-3-Trial-of-Tumor-Treating-Fields-TTFields-Therapy-for-Pancreatic-Cancer-to-be-Presented-at-2025-ASCO-Annual-Meeting
31 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250531920957/en/Results-From-the-Phase-3-PANOVA-3-Trial-of-Novocures-Tumor-Treating-Fields-TTFields-Therapy-for-Pancreatic-Cancer-to-be-Presented-at-2025-ASCO-Annual-Meeting
27 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250527097335/en/Novocure-Announces-Upcoming-Investor-Events
24 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250424750019/en/Novocure-Reports-First-Quarter-2025-Financial-Results
23 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250423058694/en/Novocure-to-Present-Results-from-the-Phase-3-PANOVA-3-Clinical-Trial-of-its-Tumor-Treating-Fields-TTFields-Therapy-for-Pancreatic-Cancer-as-a-Late-Breaking-Oral-Presentation-at-the-2025-ASCO-Annual-Meeting
22 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250422706948/en/Novocures-Optune-Lua-Receives-CE-Mark-Approval-for-the-Treatment-of-Metastatic-Non-Small-Cell-Lung-Cancer
ABOUT THIS PAGE